Kirchhof, Mark G. http://orcid.org/0000-0002-4015-8377
Prajapati, Vimal H. http://orcid.org/0000-0002-8315-2522
Gooderham, Melinda http://orcid.org/0000-0001-8926-0113
Hong, Chih-ho http://orcid.org/0000-0001-9963-8319
Lynde, Charles W. http://orcid.org/0000-0001-9163-5463
Maari, Catherine http://orcid.org/0000-0002-9719-0810
Turchin, Irina http://orcid.org/0000-0001-8654-9050
Papp, Kim A. http://orcid.org/0000-0001-9557-3642
Funding for this research was provided by:
AbbVie Canada
Pfizer Canada
Article History
Received: 3 July 2024
Accepted: 19 July 2024
First Online: 8 August 2024
Declarations
:
: The authors disclose the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Mark G. Kirchhof has been an advisor, consultant and/or speaker for: AbbVie, Arcutis, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Galderma, Incyte, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi Genzyme, Recordati, Sun Pharma, Therakos, and UCB. Vimal H. Prajapati has been an advisor, consultant, and/or speaker for: AbbVie, Actelion, Amgen, Apogee Therapeutics, Aralez, Arcutis, Aspen, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Canadian Psoriasis Network, Celgene, Cipher, Eczema Society of Canada, Eli Lilly, Galderma, GSK, Homeocan, Janssen, LEO Pharma, L’Oréal, Medexus, Novartis, Organon, Pediapharm, Pfizer, Sanofi Genzyme, Sun Pharma, Tribute, and UCB; investigator for AbbVie, Amgen, AnaptysBio, Arcutis, Arena, Asana, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Concert, Dermavant, Dermira, Eli Lilly, Galderma, Incyte, Janssen, LEO Pharma, Nimbus Lakshmi, Novartis, Pfizer, RAPT Therapeutics, Regeneron, Reistone, Sanofi Genzyme, Takeda, and UCB; and received grants from: AbbVie, Bausch Health, Janssen, LEO Pharma, Novartis, and Sanofi Genzyme. Melinda Gooderham has been a speaker, investigator, consultant or advisory board member for: AbbVie, Acelyrin, Amgen, Akros, AnaptysBio, Apogee, Arcutis, Aristea, Aslan, Bausch Health, Boehringer Ingelheim, BMS, Coherus, Dermira, Dermavant, Eli Lilly, Galderma, GSK, Incyte, InMagene, Janssen, Kyowa Kirin, LEO Pharma, Medimmune, Merck, Moonlake, Nimbus, Novartis, Pfizer, Regeneron, Reistone, Sanofi Genzyme, Sun Pharmaceuticals, Takeda, Tarsus, UCB, Union and Ventyx. Chih-ho Hong has been an investigator and/or consultant and/or speaker for: AbbVie, Amgen, Arcutis, Bausch Health, Boehringer-Ingelheim, Bristol Meyers Squibb, Celgene, Cutanea, Dermira, Dermavant, DS Biopharma, Eli Lilly, Galderma, GSK, Incyte, Janssen, LEO Pharma, Medimmune, Merck, Mirimar, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, Roche, and UCB. Charles W. Lynde has been a speaker, consultant, or principal investigator for: AbbVie, Acelyrin, Akros, Altius, Amgen, Aralez, Arcutis, Avillion, Bausch Health, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Cipher, Concert, Dermavant, Devonian, Eli Lilly, Evelo, Fresnius Kabi, Galderma, GSK, InCyte, Innovaderm, Intega Skin, Janssen, Kyowa Kirin, La Roche Posay, LEO Pharma, L’Oreal, Medexus, MedX, Merck, MoonLake, Novartis, P&G, Pediapharm, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sandoz, Sentrex, Sun Pharma, TEVA, Tribute, UCB, Valeant, Viatris, and Volo Health. Catherine Maari has been an advisor, an investigator, a consultant and/or speaker for: AbbVie, Apogee, Arcutis, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly, Galderma, Incyte, Janssen, LEO Pharma, Nimbus, Novartis, Pfizer, Sanofi Genzyme, Sun Pharma, Tarsus, Ventyx and UCB. Irina Turchin has been a speaker, consultant, or principal investigator for AbbVie, Amgen, Arcutis, Bausch Health, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Galderma, Incyte, Janssen, LEO Pharma, Mallinckrodt, Moonlake, Novartis, Pfizer, Sanofi, Sun Pharma, and UCB. Kim A. Papp has been a speaker, investigator, consultant, advisory board member, and/or scientific officer for: AbbVie, Acelyrin, Akros, Amgen, Anacor, Aralez Pharmaceuticals, Arcutis, Avillion, Bausch Health/Valeant, Boehringer Ingelheim, Bristol-Myers Squibb, Can-Fite Biopharma, Celgene, Celltrion, Coherus, CorEvitas, Dermavant, Dermira, Dice Pharmaceuticals, Dow Pharma, Eli Lilly, Evelo, Forbion, Galderma, Gilead, GSK, Incyte, Janssen, Kyowa Hakko Kirin, LEO Pharma, Meiji Seika Pharma, Merck (MSD), Mitsubishi Pharma, Novartis, Pfizer, Regeneron, Reistone, Roche, Sanofi-Aventis/Genzyme, Sandoz, Sun Pharma, Takeda, UCB, vTv Therapeutics, and Xencor.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.